1. 572 Fibroblast activating protein (FAP)-targeting IL-12 (anti-FAP/IL-12) TMEkine™ potentiates anti-cancer effects in preclinical cancer models. (9th November 2020) Authors: Kim, Donggeon; Lee, Dahea; Ryu, Soomin; Byeon, Yeongseon; Pyo, Kyoung-Ho; Kim, Jae-Hwan; Lee, Seul; Kim, Dong Kwon; Lee, Eun Ji; Oh, Seung Yeon; Cho, Byoung Chul; Lee, Byoung Chul Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform. (10th December 2020) Authors: Lee, Dahea; Kim, Donggeon; Ryu, Soomin; Lee, Byoung Chul Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform. (9th November 2020) Authors: Lee, Dahea; Kim, Donggeon; Ryu, Soomin; Lee, Byoung Chul Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗